Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Boehringer Ingelheim

Generated: May 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020587

« Back to Dashboard

NDA 020587 describes SCLEROSOL, which is a drug marketed by Lymol Medcl and is included in one NDA. It is available from one supplier. Additional details are available on the SCLEROSOL profile page.

The generic ingredient in SCLEROSOL is talc. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the talc profile page.
Summary for 020587
Applicant:Lymol Medcl
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020587
Suppliers and Packaging for NDA: 020587
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SCLEROSOL talc AEROSOL;INTRAPLEURAL 020587 NDA Bryan Corp 63256-100 63256-100-30 1 CANISTER in 1 POUCH (63256-100-30) > 30 g in 1 CANISTER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL;INTRAPLEURALStrength4GM/SPRAY
Approval Date:Dec 24, 1997TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.